Mast cells lure and trap other immune cells during allergic reactions, using their compounds to increase inflammation in a process dubbed nexocytosis ...
We are delighted to welcome Barry to Compass during this pivotal and exciting time for the company,” said Thomas Schuetz, MD, PhD, CEO of Compass and Vice Chairman of the Board of Directors. “We have ...
Following these encouraging results, Cellenkos is advancing this Phase 1 study with the addition of an expansion cohort to evaluate a modified CK0804 dosing regimen to account for the high level of ...